Skip to main content
Premium Trial:

Request an Annual Quote

New Products: Olink, Biognosys

Premium

Olink Bioscience this week launched its new Proseek Multiplex CVD protein biomarker panel.

Intended for research into cardiovascular disease, the panel allows for analysis of 92 CVD-related proteins across 96 samples simultaneously using as little as one microliter per sample, the company said. The panel uses Olink's Proseek Multiplex technology combined with Fluidigm's BioMark HD system.


Biognosys this week released a new version of its iRT kit for use in calibrating mass spec runs including shotgun and scheduled MRM experiments.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.